Perspective

Cybersecurity After an Acquisition: Lessons for Medical Device
Cybersecurity due diligence should not end when an acquisition closes. In July 2026, Abbott disclosed unauthorized access to a limited number of internal systems within its Cancer Diagnostics business, which was formed following its acquisition of Exact Sciences. Abbott stated that the incident did not affect products, manufacturing, laboratory operations, business operations, or its ability to serve patients. It also noted that legacy Exact Sciences systems remained separate from Abbott’s...



